With 40.2% CAGR, US Biosimilars Market Size worth USD 100.75 Billion by 2029 Pune, India, May 16, 2022 (GLOBE NEWSWIRE) -- The US biosimilars market size stood at USD 6.73 billion in 2021. The market is estimated to rise from USD 9.48 billion in 2022 to USD 100.75 billion by...

With 27.0% CAGR, US Biosimilars Market Size to Hit USD 30.83 Billion by 2028| US Biosimilars Industry Size, Share, Growth & Forecast Pune, India, Dec. 02, 2021 (GLOBE NEWSWIRE) -- The US Biosimilars market size is expected to gain momentum by reaching USD 30.83 billion by 2028 from USD 5.78 billion in 2021 while exhibiting a CAGR...

US Biosimilars Market to Rise at a Staggering 46.2% CAGR till 2027 | Market Projection By Technology, Major key players, Growth, Revenue, CAGR, Regional Analysis, Industry Forecast To 2027 Pune, India, Nov. 01, 2021 (GLOBE NEWSWIRE) -- The US Biosimilars Market size is projected to reach USD 22,966 million by the end of 2027. The presence of several large scale companies that are...